
A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.
A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.
Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Published: March 13th 2013 | Updated:
Published: May 23rd 2013 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.